Keyphrases
Potential Therapeutics
100%
Myotonic Dystrophy
100%
Minor Groove Binder
100%
Small Molecules
50%
Recognition Unit
50%
Structure-activity
50%
Model Cell
50%
Rationally Designed
50%
Peptidomimetics
50%
3′-untranslated Region (3′-UTR)
50%
Protein Kinase
50%
Neuromuscular Disease
50%
RNA Splicing
50%
Chromosome 19
50%
Molecular Features
50%
Activity Optimization
50%
Focus Formation
50%
Transcription Process
50%
Thiazole
50%
Autosomal Dominant
50%
Multisystemic
50%
Splicing Defect
50%
Nucleic Acid Targets
50%
Repeat Expansion
50%
New Structure Type
50%
Biochemistry, Genetics and Molecular Biology
Nucleic Acid
100%
Protein Kinases
100%
Small Molecule
100%
Transcription
100%
RNA Splicing
100%
Thiazole
100%
Chromosome 19
100%
Autosomal Dominant Inheritance
100%
Splicing Defect
100%
Peptidomimetic
100%
Medicine and Dentistry
Myotonic Dystrophy
100%
Therapeutic Agent
100%
Nucleic Acid
33%
Neuromuscular Disease
33%
RNA Splicing
33%
Protein Kinases
33%
Autosomal Dominant Inheritance
33%
Thiazole
33%
Splicing Defect
33%
Chromosome 19
33%
Peptidomimetics
33%
Pharmacology, Toxicology and Pharmaceutical Science
Myotonic Dystrophy
100%
Nucleic Acid
33%
Protein Kinases
33%
Neuromuscular Disease
33%
Lead Compound
33%
Thiazole
33%
Messenger RNA Precursor
33%
Peptidomimetics
33%